In this first webinar, we will cover various applications for NGS and different aspects of comprehensive genomic tests, including variants, CNVs, rearrangements, MSI, mutational signatures, TMB, and more. Additionally, we will briefly touch on different types of tests such as ctDNA and MRD to provide a sense of the testing landscape.
Learning Objectives:
Understand the various use cases for next generation sequencing (NGS) in the clinical oncology diagnostics space
Recognize the various approaches for detecting somatic mutations and why comprehensive genomic profiling is beneficial for patient outcomes
Understand the scope of NGS comprehensive oncology panels, the different types of biomarkers they are capable of detecting, and their utility
Identify the benefits of sequencing both DNA and RNA from the same patient sample
Know how relevant mutational signatures may be included in a comprehensive genomic panel, how they are determined and their actionability